|
Volumn 353, Issue 9171, 1999, Pages 2250-
|
Research funding [19]
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
COST EFFECTIVENESS ANALYSIS;
DRUG RESEARCH;
FINANCE;
HUMAN;
LETTER;
PRIORITY JOURNAL;
PUBLICATION;
STROKE;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CEREBROVASCULAR DISEASE;
CLINICAL TRIAL;
CONFLICT OF INTEREST;
CONTROLLED CLINICAL TRIAL;
DRUG INDUSTRY;
ECONOMICS;
ETHICS;
EVIDENCE BASED MEDICINE;
FINANCIAL MANAGEMENT;
MEDICAL RESEARCH;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
UNITED KINGDOM;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
BIOMEDICAL RESEARCH;
CEREBROVASCULAR DISORDERS;
CONFLICT OF INTEREST;
DRUG INDUSTRY;
ETHICS;
EVIDENCE-BASED MEDICINE;
GREAT BRITAIN;
HUMANS;
RANDOMIZED CONTROLLED TRIALS;
RESEARCH SUPPORT;
|
EID: 0033606376
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(05)76309-1 Document Type: Letter |
Times cited : (2)
|
References (2)
|